T N Vlasik Selected Research

F(ab')2 receptor

1/2005	[Results of clinical trials of a novel glycoprotein IIb-IIIa antagonist framon in high-risk coronary angioplasty].
12/2002	Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.
1/2002	[Pharmacodynamics, safety, and clinical effects of a novel glycoprotein IIb/IIIa antagonist framon during high risk coronary angioplasty].
1/2001	[Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T N Vlasik Research Topics

Disease

7	Hypersensitivity (Allergy) 01/2010 - 01/2001
5	Myocardial Infarction 05/2010 - 01/2002
4	Thrombocytopenia (Thrombopenia) 01/2005 - 01/2001
3	Atherosclerosis 08/2010 - 10/2005
2	Hemorrhage 04/2022 - 01/2001
2	Thrombosis (Thrombus) 04/2022 - 01/2005
2	Diabetes Mellitus 01/2014 - 08/2010
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2013 - 05/2004
2	Infections 01/2010 - 01/2009
2	Pulmonary Tuberculosis 01/2010 - 01/2009
1	No-Reflow Phenomenon 04/2022
1	Acute Coronary Syndrome 04/2022
1	Coronary Thrombosis 04/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2016
1	Heart Diseases (Heart Disease) 12/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2016
1	Chagas Disease (American Trypanosomiasis) 12/2016
1	Ischemia 12/2015
1	Inflammation (Inflammations) 05/2010
1	Heart Neoplasms 03/2008
1	Myxoma (Myxomas) 03/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2007

Drug/Important Bio-Agent (IBA)

4	F(ab')2 receptorIBA 01/2005 - 01/2001
3	oxidized low density lipoproteinIBA 08/2010 - 10/2005
2	AutoantibodiesIBA 12/2016 - 12/2016
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2014 - 01/2013
2	CholesterolIBA 08/2010 - 11/2005
2	AntigensIBA 01/2010 - 01/2009
2	Tuberculin (PPD)IBA 01/2010 - 01/2009
2	Interferon-gamma (Interferon, gamma)IBA 01/2010 - 01/2009
2	AntibodiesIBA 01/2005 - 05/2004
1	Platelet Membrane GlycoproteinsIBA 04/2022
1	Prasugrel Hydrochloride FDA Link 04/2022
1	Clopidogrel (Plavix)FDA Link 04/2022
1	TicagrelorIBA 04/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Ezetimibe (Zetia)FDA Link 01/2013
1	Simvastatin (Zocor)FDA LinkGeneric 01/2013
1	Biomarkers (Surrogate Marker)IBA 08/2010
1	Glyoxal (Ethanedial)IBA 08/2010
1	LDL CholesterolIBA 08/2010
1	Pyruvaldehyde (Methylglyoxal)IBA 08/2010
1	CytokinesIBA 05/2010
1	CCR5 Receptors (CCR5 Receptor)IBA 05/2010
1	Interleukin-6 (Interleukin 6)IBA 05/2010
1	C-Reactive ProteinIBA 01/2010
1	BCG Vaccine FDA Link 01/2009
1	Mycobacterium tuberculosis antigensIBA 01/2009
1	Group II Phospholipases A2IBA 03/2008
1	DystrophinIBA 05/2007
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 05/2007
1	LipidsIBA 10/2005
1	Pharmaceutical PreparationsIBA 01/2005
1	monaframIBA 05/2004
1	Abciximab (ReoPro)FDA Link 01/2002
1	Platelet Membrane Glycoprotein IIbIBA 01/2002

Therapy/Procedure

2	Therapeutics 04/2022 - 01/2013
1	Percutaneous Coronary Intervention 04/2022